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We describe the specific silencing of reporter gene lacZ in FHM cells (muscle cells of fathead minnow, a fish cell line) by either
expressing small hairpin RNAs (shRNAs) from plasmids or transfecting small interfering RNAs (siRNAs) transcribed in vitro. Two types of
dsRNAs could inhibit reporter gene expression, and siRNAs were more effective, while both of them worked very well in HeLa cells.
siRNAs were tested for silencing expression of the major capsid protein (MCP) encoded by tiger frog virus (TFV), an iridovirus causing
severe disease in fish. siRNAs targeting mcp gene effectively inhibited TFV replication in fish cells as demonstrated by reduced mcp RNA
level, postponed emergence of cytopathogenic effect, as well as reduced TFV titer and particles in cells. The results suggest that the siRNA
method suppressed TFV efficiently in fish cells, providing a potential approach to the therapy of aquaculture viral diseases.
D 2005 Elsevier Inc. All rights reserved.Keywords: RNA interference; shRNA; siRNA; TFVIntroduction
During the last three decades, aquaculture (fish, crusta-
ceans, molluscs, and plants) has been one of the fastest
growing sectors of the agrifood industry. The worldwide
production of farmed fish and crustaceans alone accounted
for 48.2 million tons in 2001, valued at US$ 60.9 billion and
with average annual growth rates of 9.2% since 1971 (2002
State of World Fisheries and Aquaculture report, FAQ, Feb,
2003). However, along with the rapid expansion of
aquaculture industry, the diseases of aquatic products have
become a more and more severe problem and have caused
huge economical losses. The actual economic losses in the
aquaculture industry worldwide are estimated to be in0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.04.040
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1 These authors contributed equally to this work.excess of US$ 9 billion per year, which is about 15% of the
value of world’s farmed fish and crustacean production
(http://www.intervet.com/aah/diseases.asp). Among these
diseases, viral infection of aquatic animals posts as a great
threat in aquaculture. Significant economic losses in
cultured fish worldwide have been attributed to outbreaks
of iridovirus infections in aquaculture in recent years.
Especially, iridoviruses have been reported to infect some
commercially important aquatic animals, such as rainbow
trout, sheatfish, grouper, and catfish (Bloch and Larsen,
1993; Chou et al., 1998; Chua et al., 1994; He et al., 2000;
Langdon et al., 1988; Matsuoka et al., 1996; McGrogan et
al., 1998; Miyata et al., 1997; Nakajima et al., 1998; Plumb
et al., 1996; Pozet et al., 1992; Rodger et al., 1997; Weng et
al., 2002). Currently, the effective prevention of iridovirus
infection in aquaculture remains to be developed.
RNA interference (RNAi) is a natural biological mech-
anism for silencing genes in most cells of many living
organisms, from plants to fruit flies (Drosophila mela-005) 43 – 52
Fig. 1. Transfection and detection of h-galactosidase activities in FHM
cells. (A–C) Comparison of calcium phosphate coprecipitation with
cationic lipid reagents as DNA carriers for transfection. For 24-well plate,
transfections were carried out using h-galactosidase plasmid pCMV–lacZ
(0.4 Ag) by Lipofectin reagent (1.5 Al) (A) or Lipofectamine 2000 (1.5 Al)
(B) or calcium phosphate coprecipitation method (C). (D–L) Analysis of
siRNA-mediated inhibition of h-galactosidase gene in FHM cells. FHM
cells in 96-well plate were cotransfected by using 0.5 Al Lipofectamine
J. Xie et al. / Virology 338 (2005) 43–5244nogaster), nematodes (Caenorhabditis elegans) to verte-
brate (Fire et al., 1998; Fjose et al., 2001). Although the
molecular mechanism by which RNAi-mediated gene
regulation is yet to be fully understood, a considerable
interest is focused on the potential therapeutic applications
of these molecules, particularly in preventing viral infec-
tions (Andino, 2003). RNAi is a sequence-specific post-
transcriptional gene silencing mechanism, which is triggered
by double-stranded RNA (dsRNA) and causes the degrada-
tion of mRNAs homologous in sequence to the dsRNA
(McManus and Sharp, 2002). Small interfering RNA
(siRNA) of exogenous origin or produced in nucleus from
long precursors (Carmichael, 2002) assembles with the
cytoplasm protein to form silencing complexes. Targeted
mRNA that matched one strand of the dsRNA are cleaved
and destroyed by the silencing complexes. The targets
include mRNA copies of cellular genes or genes of an
invaded virus. Thus, RNAi is a useful cellular approach to
regulate gene expression and a potential approach to fight
viral infection (Carmichael, 2002). Indeed, recent studies
have shown that siRNA can be employed to silence the
expression of exogenous viral gene in insect cells (Adelman
et al., 2002; Means et al., 2003), plant cells (Yelina et al.,
2002), and mammalian cells (Coburn and Cullen, 2002;
Gitlin et al., 2002; Hall and Alexander, 2003; Jacque et al.,
2002; Jia and Sun, 2003; Jiang and Milner, 2002; Lee et al.,
2002; McCaffrey et al., 2003; Novina et al., 2002; Seo et al.,
2003; Shlomai and Shaul, 2003; Surabhi and Gaynor, 2002;
Wiebusch et al., 2004). The results of these studies suggest
the possibility of using RNAi as an antiviral tool.
RNAi in vertebrate was first demonstrated in zebrafish
(Danio rerio) embryos (Li et al., 2000; Wargelius et al.,
1999) and was later extended in Xenopus (Nakano et al.,
2000) and mouse embryos by injecting long dsRNAs
(Wianny and Zernicka-Goetz, 2000). TFV belongs to genus
Ranavirus and it is the causative agent of a disease causing
severe tadpole mortalities in commercial cultures in China
(Weng et al., 2002). In the present study, we demonstrated
the feasibility to inhibit lacZ reporter gene expression in fish
cells by siRNA transcribed in vitro or by shRNA (small
hairpin RNA) generated from plasmids transfected into the
target cells, suggesting that RNAi-mediated mechanisms do
regulate gene expression in fish. Furthermore, we showed
that siRNAs targeting the mRNA of TFV major capsid
protein (MCP) gene effectively inhibited TFV replication in
cultured fathead minnow muscle cells (FHM), indicating
that siRNAs might represents a potential therapeutic or
preventive approach against fish viral diseases.
2000 and 0.1 Ag pCMV–lacZ and 500 nM of silacZc control (D), silacZ1
(E), or silacZ3 (F), 1 Ag of pSilencer 1.0 plasmid control (G), pSilencer-
silacZ1 (H), or pSilencer– silacZ3 (I), 1 Ag of pSHAG-1 plasmid control
(J), pSHAG-silacZ1 (K), or pSHAG–silacZ3 (L). (M–R) Analysis of
dsRNA-mediated inhibition of lacZ expression in HeLa cells. HeLa cells in
96-well plate were cotransfected by using 0.5 Al Lipofectamine 2000 and
0.1 Ag of pCMV–lacZ and 500 nM of silacZc control (M), silacZ3 (P), 1
Ag of pSilencer 1.0 plasmid control (N), pSilencer– silacZ3 (Q), 1 Ag of
pSHAG-1 plasmid control (O), pSHAG–silacZ3 (R). Cells of all panels
were stained and photographed at 48 h after transfection.Results
Transfection of reporter gene in FHM cells
Compared to that in HeLa cells, the transfection
efficiency of foreign DNA in FHM cells appears to be
Fig. 2. siRNA and inhibition of lacZ reporter gene expression. The predicted secondary structure of dsRNAs generated by pSilencer 1.0 (A) and pSHAG-1 (B)
was depicted. The arrows indicated the antisense strand of the shRNAs targeting lacZ. (C) Comparison of the silencing effect of three kinds of siRNAs
molecules. 0.1 Ag of pCMV– lacZ and various amounts of silacZ1, silacZ2, and silacZ3 siRNAs were cotransfected. The level of h-galactosidase activity was
determined 48 h after transfection. (D) Comparison of the silencing effect of different kinds of dsRNAs molecules. 0.1 Ag pCMV– lacZ and 500 nM of silacZ3,
or 1 Ag of pSilencer 1.0 plasmid control, or 1 Ag of pSilencer– silacZ3 plasmid were cotransfected. All assays were performed on FHM cells in 96-well plate
using 0.5 Al Lipofectamine 2000. All the data shown represented means for three experiments with 2 standard deviations indicated by error bars.
Table 1
The siRNA sequences (sense strand) in this study
Name Target sequence Position in gene
sequence
lacZ mcp
silacZ1 5V-CGUGAUUUUCGUUGCCGGUUU-3V 60
silacZ2 5V-UCACCCGAGUGUGAUCAUCUU-3V 1452
silacZ3 5V-CUGCUCCAAAGAAGAAGCGUU-3V 3176
silacZca 5V-CGUGAUGCUCGUUGAUGCGUU-3V
Si1 5V-CGCCUGGUUGGUACUCAAGUU-3V 237
Si2 5V-CAGUCAAGCUGAGGGCCAUUU-3V 626
Si3 5V-UUACGGCAGACUGACCAACUU-3V 1206
M1b 5V-CGCCUGAUUGGUACUCAAGUU-3V
M4b 5V-CGCCUGACCAGUACUCAAGUU-3V
a Mutation of silacZ1 with irrelevant sequence.
b Mutated siRNAs of Si1 have one or four mismatch nucleotides,
respectively.
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transfection conditions, we compared the effect of three
kinds of transfection methods in introducing pCMV–lacZ
reporter gene in FHM cells. After 48 h of transfection, the
results of h-galactosidase staining showed that cationic lipid
reagents, Lipofectine (Fig. 1A) and Lipofectamine 2000
(Fig. 1B), clearly displayed higher transfection efficiency
than calcium phosphate coprecipitation method (Fig. 1C),
and Lipofectamine 2000 (Fig. 1B) was demonstrated the
highest transfection efficiency. We therefore selected Lip-
ofectamine 2000 as the DNA carrier for further transfection
assays.
Silence of reporter gene by RNAi
DNA inserts of shRNAs targeting lacZ were ligated to
pSHAG-1 or pSilencer 1.0 vector, under control of U6
promoters. The recombinant vectors and siRNAs tran-
scribed in vitro were cotransfected with pCMV–lacZ
plasmid into cells, respectively. The predicted secondary
structures of the shRNAs are shown in Figs. 2A and B. Figs.
1D–L showed the X-Gal staining of h-galactosidase
activities after 48 h of cotransfection. In FHM cells, the
siRNAs (Figs. 1E–F) obtained from in vitro transcription
and the shRNAs (Figs. 1H–I, pSilencer, and Figs. 1K–L,
pSHAG) intracellularly expressed in cells from shRNA
expression plasmids can reduce the expression of lacZ
reporter gene. Quantitative h-galactosidase assays using o-
nitrophenylglucoside (ONPG) as a substrate showed that the
silencing effect caused by siRNAs was about 8-fold than
that of shRNAs. In HeLa cells, both shRNA and siRNA
induced robust inhibition of the expression of reporter gene
to a very low level (Figs. 1M–R). The inhibition
efficiencies of shRNAs expressed from plasmids (Figs. 1Qand R) were slightly inferior to that of siRNAs transcribed
in vitro (Fig. 1P) both in X-Gal staining and quantitative
assay. The ideal inhibition effect of shRNAs in HeLa cells
could not be maintained in FHM cells.
To identify a potent siRNA molecule in our study, we
designed and tested three siRNA and shRNA sequences
for lacZ gene. As shown in Figs. 1D–L, we compared
the silencing efficiency of the dsRNAs targeting various
positions in lacZ gene, dsRNAs with no homology to
lacZ gene serving as controls (Table 1). We found that
dsRNAs of the third position including silacZ3 (Fig. 1F),
pSilencer–silacZ3 (Fig. 1I), and pSHAG–silacZ3 (Fig.
1L) were the strongest silencers, followed by dsRNAs of
the first and second position including silacZ1 (Fig. 1E),
silacZ2 (similar to silacZ1, data not shown), pSilencer-
silacZ1 (Fig. 1H), pSilencer-silacZ2 (similar to pSilencer-
silacZ1, data not shown), pSHAG-silacZ1 (Fig. 1K), and
Fig. 3. Anti-TFV siRNAs target selection and experimental design. (A)
Three of 19 nt gene-specific sequences following AA locate at 237, 626,
and 1206 nucleotides downstream from the translation initiation AUG
codon of mcp was respectively shown pro rata in mcp gene (translucent
strip). The secondary structure of Si1 dsRNA ended with UU at 3V terminals
was depicted. The upper strand of sequence indicates the sense strand. (B)
Experimental scheme of siRNA-mediated RNAi for anti-TFV. In the graph,
the time of samples collection includes 1–72 hpi at 14 time-intervals as
indicated by small arrows. The time of TFV infection was set to zero, and
siRNAs transfection was performed 4 h before infection.
Fig. 4. siRNA-mediate mcp-specific RNAi in FHM. (A–C) Transfection efficien
vision of transfected cells under fluorescence (A) and bright-field (B) microsc
efficiencies were 65%¨85% due to analysis using SimplePCI software. (D–H) S
infected with same M.O.I. TFVafter transfected with different types of nucleic acid
post-infection (hpi), mock-transfected control cells (H) and other samples were p
RNAi. Four time-intervals of mock-transfected control cells (I –L) and Si1-transfe
viral plaques in the panels represented the less quantity of TFV infection. (I–L) sho
(M–P) represented Si1-transfected FHM cells at corresponding time intervals. The
FHM cells were indicated by arrows.
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shown). We also tested the silencing effect of silacZ1,
silacZ2, and silacZ3 at different concentrations to
determine the optimal amounts of siRNAs used in the
cotransfection assays by Lipofectamine 2000 method. The
results of quantitative h-galactosidase assays (Fig. 2C)
were similar to the results of the X-Gal staining. As
shown in Fig. 2C, siRNAs dose-dependently suppressed
lacZ expression at the range from 0 to 500 nM. In
addition, no toxicity to the cells was observed within this
concentration range of siRNA. Therefore, we chose
silacZ3 in our further studies.
To compare the silencing effects of siRNA and
shRNA, analyses of h-galactosidase activities at 12 h,
24 h, 48 h, and 72 h post-transfection of silacZ3,
pSilencer–silacZ3, and pSilencer 1.0 control were per-
formed respectively. Fig. 2D showed that silacZ3
inhibited the expression of lacZ reporter gene more
efficiently than that of pSilencer–silacZ3, and the strong
inhibition persisted until 72 h.cy. FAM labeled Si1 was transfected into FHM cells and the same field of
ope were shown. Overlapped of two views (C) showed that transfection
ilencing effect of different types of nucleic acids to TFV. FHM cells were
s: Si1 siRNA (D), dsDNA (E), sense ssRNA (F), antisense ssRNA (G). 60 h
hotographed. (I–P) Emergence of CPE of infected cells was postponed by
cted cells (M–P) were shown. The more the adherent cells and the less the
wed the state of mock-transfected FHM cells at 20, 36, 60, 72 hpi, and panel
bars in the panels represent 100 Am. The viral plaques formed in monolayer
Fig. 5. Reduction in viral production by mcp-specific siRNAs. (A) TFV
RNAs were reduced by RNAi. Results of semi-quantitative RT-PCR
detected a 532-bp fragment of mcp gene and a 281-bp fragment of 18S
rRNA gene which served as internal control. 078 and 061 genes of
TFV were also amplified using their corresponding primer sets and the
972-bp and 552-bp fragments of 14 time-intervals (1–72 hpi) were
shown in ranges of the genes respectively. Under each panel of gel
image, expression trendlines according to expression rate of 078 gene
(up panel), 061 gene (middle panel), and mcp gene (down panel) of 14
time-intervals were presented. Based on the normalized average value of
corresponding bands, expression rate of the three genes in each sample
was generated. 18S fragments at top of the figure served as internal
control. (B) Titer of TFV was decreased by RNAi. The average titers of
4 time-intervals samples were shown in lgTCID50. The data shown in
graphs represented averages for three experiments with 2 standard
deviations indicated by error bars. Si1, Si2, and Si3 represented siRNAs
targeting mcp gene in three different position; M1 and M4 represented
Si1-mutant siRNAs with 1 and 4 mismatch nucleotides, respectively; C
represented mock-transfected control.
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Three RNAi targeting sequences located at 237, 626,
1206 nucleotides downstream of the translation initiation
AUG codon of MCP gene of TFV were chosen (Fig.
3A). The GC content of three siRNAs corresponding to
the target sequences was approximately 50%. At the
same time, the mutated siRNAs of Si1 were constructed.
M1 and M4 were mutated one and four nucleotides
respectively. Si1 siRNA was labeled with the FAM
fluorescent dye and transfected into FHM cells. The
transfected cells were examined microscopically under
fluorescence (Fig. 4A) and bright-field (Fig. 4B) 6 h after
transfection. Overlapped of two views (Fig. 4C) were
analyzed with SIMPLEPCI software (Version 5.3.1.081004)
and the transfection efficiencies were approximately
65%–85%.
To compare the silencing effects, FHM cells were
transfected with different nucleic acids before infection
and the cytopathogenic effect (CPE) of infected cells was
examined at 60 h post-infection (hpi). Si1 siRNA (Fig.
4D) strongly inhibited TFV replication and restrained
cells from forming TFV plaques much more efficiently
than nucleic acids with identical target sequence including
dsDNA (Fig. 4E), sense ssRNA (single strand RNA)
(Fig. 4F), and antisense ssRNA (Fig. 4G). No inhibition
was observed in the control, mock-transfected cells (Fig.
4H), and other types of nucleic acids. Thus, we chose
siRNA in our further studies on RNAi-mediated inhib-
ition of TFV infection.
Delayed emergence of CPE of TFV-infected cells by RNAi
CPE is the most intuitionistic parameter for the quantities
of TFV. CPE reflects the viral quantity of virus accumu-
lation (Williams, 1996). Since CPE of infected FHM will
not appear within 20 hpi even in mock-transfected control,
analyses of CPE in FHM cell were carried out at four time-
intervals after siRNAs transfection and TFV infection from
20 hpi to 72 hpi (Fig. 3B). The CPE of mock-transfected
control cells (Figs. 4I–L) were much more severe than that
of Si1-transfected cells (Figs. 4M–P) at all four time-
intervals. At 20 hpi, while CPE of cell enlargement,
detachment, and viral plaques on monolayer cells were
present in control samples (Fig. 4I), no obvious CPE was
observed in Si1-transfected cells (Fig. 4M), but CPE was
first detected at 36 hpi in Si1-transfected cells (Fig. 4N). At
60 hpi, as compared with the Si1-transfected cells (Fig. 4O),
the control cells (Fig. 4K) displayed more severe CPE with
an increased number of detached or morphologically
abnormal cells and increased amount and size of viral
plaques. The CPE of Si1-transfected cells at 76 hpi (Fig. 4P)
was similar to the control cells at 36 hpi (Fig. 4J),
suggesting that Si1 siRNA could down-modulate the
propagation of TFV and postpone the emergence of CPE
for approximately 36 h.
Fig. 6. Reduction of TFV particles in FHM cells by RNAi. Electron
microscopy image of cells of mock-transfected controls (A–D) and Si1-
transfected cells (E–H) were shown. There were no TFV virions found in
20 hpi (E), 36 hpi (F), and 60 hpi (G) samples of Si1-transfected cells. In
the samples of mock-transfected control cells, there was also no virion
found in 20 hpi sample (A), but a lot of virions found in 36 hpi sample (B).
In panel (B), the enlarged image of arrow pointed area was shown in the left
and well arrangement of virions can be seen. A large number of virions
were seen in the 60 hpi sample of mock-transfected control cells (C) and
mature virions broke through the cell membrane to induce cell destruction,
which can be seen in 72 hpi sample of mock-transfected control cells (D).
Only a few sporadic virions in 72 hpi sample of Si1-transfected cells (H).
The bars in the panels represent 2 Am. TFV virions were indicated by
arrows.
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We examined if treatment with Si1, Si2, Si3, M1, and M4
siRNAs resulted in a reduced level of TFV RNAs presented
in FHM cells, semi-quantification of highly sensitive RT-
PCR analyses was carried out to compare the relative
silencing effects. To every siRNA or mock-transfection
control, 14 time-intervals (Fig. 3B) samples were analyzed.
The M-in primer set was used to amplify a 532 bp
fragment of mcp, and the 18S primer set amplified a 281-bp
fragment of 18S rRNA which served as an internal control.
078, the relative early gene, and 061, the relative late gene,
of TFV were also amplified using their corresponding
primer sets, and the 972-bp and 552-bp fragments were
respectively performed semi-quantification as well. The gel
images and corresponding expression trendline of each
sample were shown in Fig. 5A. In all time-intervals samples,
the marked inhibition of mRNA of mcp by Si1 can be seen
(Fig. 5A, down panel). After normalization to the 18S rRNA
internal control, the average expression level of 14 time-
intervals cells treated with M4, M1, Si3, Si2, and Si1 are
97.4%, 95.5%, 43.8%, 37%, and 0%, representing a 2.6%,
4.5%, 56.2%, 63%, and 100% reduction of TFV RNAs
compared to that (100%) of mock-transfected controls,
respectively (Fig. 5A). While Si1 showed strong inhibition
of TFV RNA at all time-intervals, Si2 and Si3 also showed
certain inhibition in the early stages post-infection (Fig. 5A,
1–18 hpi), but inhibition abilities of Si2 and Si3 gradually
waned down in the late stages post-infection (Fig. 5A, 60
hpi and 72 hpi). Compared with Si1 treated cells, the
mutated siRNAs, M1 and M4, respectively possessed more
TFV RNAs, indicating that siRNA-mediated silencing
effects were sequence-specific to target gene. Si1 siRNA
suppressed the mRNA of mcp gene (Fig. 5A, gel image of
down panel) but not the mRNA of 078 and 061 gene (Fig.
5A, gel images of up and middle panels) from 1 hpi to 18
hpi, indicating that RNAi of Si1 in FHM anti-MCP is gene-
specific. From 20 hpi to 72 hpi, the increase of mRNAs
amounts of 078 gene and 061 gene in Si1 transfected
samples (Fig. 5A, graphs of up and middle panels) were
lowered gradually relative to mock-transfected control.
Reduction of TFV titer and particles in cell culture by RNAi
To test whether RNAi could impede the packaging and
production of infectious TFVs, TFV titers of were determined
using 20, 36, 60, and 72 hpi cell culture supernatants. The
average titers of Si1 (1.09 lgTCID50ml
1), Si2 (2.2 lgTCID50
ml1), and Si3 (2.73 lgTCID50 ml
1) treated cells from
samples of four time-intervals were 103.6-fold (3.98  103-
fold), 102.49-fold (309-fold), and 102.56-fold (91.2-fold) lower
than those of the mock-transfected controls (4.69 lgTCID50
ml1), respectively (Fig. 5B). As shown in Fig. 5A, Si1
blocked the mRNA level resulting in the reduction of the
number of infectious TFVs and the formation of TFV
particles. Compared with Si1, Si2, and Si3 exhibited less
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reduction in TFV titers. Furthermore, the average TFV titers
generated by cells transfected with Si1-mutant M4 (4.69
lgTCID50 ml
1) and M1 (4.4 lgTCID50 ml
1) were 103.31
(2.0  103) and 102.81 (645.7) times higher than that by Si1-
treated cells respectively, further confirming the sequence-
specific inhibition effect of RNAi.
To detect the formation of TFV particles in FHM cells,
we examined the infected cells at different time-intervals
from 20 hpi to 72 hpi using electron microscopy. While
TFV virions were first present in cells of mock-transfected
control at 36 hpi (Fig. 6B), no virions were seen until 72 hpi
in Si1-transfected cells (Fig. 6H). Larger numbers of
hexagonal virions were packaged and arranged orderly in
the cytoplasm of mock-transfected control cells after 36 hpi
(Figs. 6B–D). The mature virions breaking through the cell
membrane resulted in cell destruction could be seen in the
72 hpi sample of mock-transfected control cells (Fig. 6D).
In the 72 hpi sample of Si1-transfected cells (Fig. 6H),
several sporadic virions were present in the cytoplasm with
no regular arrangement. Formation of mature TFV virions
was significantly abrogated by Si1.Discussion
There has been considerable interest in developing RNAi
therapeutics to treat a wide range of diseases. Recent reports
have suggested that RNAi can be used therapeutically in
mammals (McManus and Sharp, 2002). It has already been
demonstrated in zebrafish (Danio rerio) embryos that RNAi
can inhibit exogenous and endogenous genes expression by
microinjecting long dsRNAs (Fjose et al., 2001; Li et al.,
2000; Wargelius et al., 1999). The present work has proved
that RNAi can inhibit reporter gene expression and TFV
replication in FHM cells. Thus, it may be possible to use
siRNAs to fight directly against the viral or host genes and to
inhibit viral replication in fish cells. RNAi provides a useful
tool for further study of functional gene in fish cells and for
prevention and treatment of viral diseases in aquatic animals.
Comparing the silencing effects of different types of
nucleic acids, including dsDNA, sense ssRNA, antisense
ssRNA, siRNA derived from in vitro transcription, and
shRNA expressed intracellularly from plasmids, our results
have shown that both siRNAs and shRNAs exhibit strong
suppression effects in fish cells while dsDNA, sense
ssRNA, and antisense ssRNA have no effects. Interestingly,
while siRNAs and shRNAs induce the same significant
silencing effect in HeLa cells, the siRNAs synthesized by in
vitro transcription exhibited far more potent silencing effect
than shRNAs expressed intracellularly under the U6
promoter in FHM cells.
In this study, we provided evidence that RNAi substan-
tially inhibited TFV replication in FHM cells as judged by:
(i) gene-specific reduction of mcp mRNA in 1–18 hpi, and
reduction of TFV RNAs in 20–72 hpi; (ii) postponement ofCPE in FHM cells for approximately 36 h; (iii) decrease of
TFV virions to undetectable levels in 60 h; and (iv)
suppression in the titer of TFV. We selected the mcp as
the RNAi target and detection marker for TFV. mcp is a
highly conserved gene and has proved to be a valuable
indicator in viral evolutional (Tidona et al., 1998) and
comparative studies of iridovirus. It encodes MCP, the
major structural component of virus particles, comprising
40–45% of the total viral protein (Schnitzler and Darai,
1993) and MCP is a late gene product (Williams, 1996). We
showed that three selected siRNAs could induce silencing of
mcp in the early stages of infection though the silencing
effect of Si2 and Si3 diminish after 60 hpi. The loss of
inhibiting effects of Si2 and Si3 may relative to the
replication mechanism of TFV (Williams, 1996).
In summary, the work presented here suggests that RNAi
can effectively induce gene silencing in FHM cells and that
RNAi can be applied to antiviral purpose in virus-cell of
aquatic system to treat or prevent infectious diseases from
aquatic viruses, such as iridovirus.Materials and methods
Cells and plasmids
FHM cells were grown at 29 -C in M199 medium
(GIBCO, USA) supplemented with 10% fetal bovine serum
(Hyclone, USA), 100 U ml1 penicillin, and 100 Ag ml1
streptomycin in a 2.5% CO2-humidified chamber. HeLa
cells were grown at 37 -C in DMEM medium (GIBCO,
USA) supplemented with 10% fetal bovine serum (Hyclone,
USA), 100 U ml1 penicillin, and 100 Ag ml1 streptomy-
cin in a 5% CO2-humidified chamber. pCMV–lacZ plasmid
containing h-galactosidase cDNA driven by CMV promoter
was constructed by Dr. Lin Gan (unpublished). Plasmid
DNAwas purified by the method of CsCl-ethidium bromide
gradient centrifugation and kept in saline at 20 -C until
use. The purity of the plasmid preparations was verified by
absorbance at 260 and 280 nm and 1% agarose gel
electrophoresis. The reagents used in histochemical analysis
of h-galactosidase gene expression were from Sigma (St
Louis, MO, USA).
dsRNA preparation
dsRNAs used to target lacZ gene and ORF 96 (the MCP
gene, He et al., 2002) of tiger frog virus (TFV, Genbank
accession number NC_003407) are listed in Table 1.
dsRNAs were generated using Silencer siRNA Construction
Kit (Ambion, USA) or vectors that express small hairpin
RNAs (shRNAs) under the control of the mouse U6
promoter, including pSHAG-1 in which the antisense strand
is first transcribed (Paddison et al., 2002; provided by Dr. J.
Miano) and pSilencer 1.0 vector in which the sense strand is
first transcribed (Ambion, USA).
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duplexes for the target mRNA sequence (Elbashir et al.,
2001), we searched for appropriate GC content sequences of
the type AA (N21) [N, any nucleotide (nt)] from the open
reading frame of the targeting gene, in order to obtain a 21-
nt sense and a 21-nt antisense strand with 2-nt 3V overhangs.
The dsRNAs were hybridized by two complementary
ssRNAs which were in vitro transcribed from separate
dsDNA templates containing T7 promoter. The siRNAs
were purified, quantified by absorbance at 260 nm and
labeled with fluorescein (FAM, carboxy-fluorescein) using
Silencer siRNA Labeling Kit (Ambion, USA) by following
the manufacturer’s protocol.
Transfection, infection and gene expression assays
The day before transfection, cells were trypsinized, diluted
with the fresh medium without antibiotics, and seeded into
culture plates. Cotransfection with the reporter plasmid and
lacZ-siRNAs or the vectors expressing shRNAs in cells was
carried out using calcium phosphate coprecipitation method,
Lipofectin reagent or Lipofectamine 2000 (Invitrogen, USA)
according to the manufacturer’s instructions. Histochemical
analysis of h-galactosidase activity was performed according
to previously published procedure (Wargelius et al., 1999). In
brief, 24 h after transfection of pCMV–lacZ, the cells were
fixed in 4% paraformaldehyde in PBS for 5–10 min, washed
with PBS and stained in X-Gal solution for 2 h to 2 days.
Quantitative lacZ assays using o-nitrophenylglucoside
(ONPG) as a substrate were performed after the protocol
provided in Molecular Cloning (Sambrook et al., 1989). In
brief, cells were washed with PBS, lysed with Triton X-100
and mixed with ONPG solution at 37 -C for 5–30 min. After
adding sodium phosphate solution to stop reaction, the
mixture was measured the A420 using Pharmacia Biotech
Ultrospec 2000 and BIO-RAD Microplate Reader (model
550).
FHM cells were transfected with SiPORT Lipid
(Ambion, USA) in the presence of 300 nM TFV-siRNAs
according to the manufacturer’s protocol. Transfected cells
were washed twice with fresh medium and examined under
bright-field illumination and fluorescence (wavelength 490
nm) using a Nikon Eclipse TE-2000U microscope. Captured
images were analyzed using SIMPLEPCI V. 5.3.1.081004
(Compix Inc., Imaging Systems, USA).
Infection of TFV (MOI = 20) was performed 4 h after
siRNA’s transfection (Fig. 3B).
Semi-quantitative RT-PCR
1 Ag RNase-free DNase treated total RNA isolated from
about 1  104 transfected and infected FHM cells of all
time-intervals with RNeasy\ Kit (Qiagen, Germany) was
reverse transcribed by M-MLV Reverse Transcriptase
(GIBCO, USA) and aliquot of RT products were subjected
to semi-quantitative PCR as described previously publishedprocedure (Chamizo et al., 2001). Semi-quantitative PCRs
were performed using the M-in primer set (M-inF: 5V-
GACTTGGCCACTTATGAC-3V, M-inR: 5V-TGTCTCT-
GGAGAAGAAGAA-3V), 18S rRNA gene primer set (18SF:
5V-ATGGTACTTTAGGCGCCTAC-3V, 18SR: 5V-TATAC-
GCTATTGGAGCTGG-3V), 078 gene primer set (078F: 5V-
ATGGAATGCATCTACTGTTT-3V, 078R: 5V-GATAAT-
GTTAAATTTTGTCAGG-3V) or 061 gene primer set (061F:
5V-ATGAGGATCTTTGGATCCGC-3V, 061R: 5V-CTTTC-
TATTGTCCATCCAAGCG-3V). After electrophoresis, the
gels were photographed and images were analyzed by the
AlphaEase FC imaging system (Alpha Innotech Corpora-
tion, USA). The pixel value (intensity) and area of each band
in every image was counted and the background of certain
image as well. The average value (AVG) was calculated by
the equation, which was suggested by the system manual, as
followed: AVG = [~(each pixel value  background)]/area.
The results can eliminate the error of different exposure time
from image to image, and the error of different band area
generated by various gel running conditions. The datum of
AVG of bands of mcp, 078, and 061 fragments were
normalized to the RT-PCR fragment of 18S rRNA gene to
get normalized AVG (nAVG). nAVG of each siRNA trans-
fected samples at 14 time-intervals generated the expression
trendline, named the ‘‘expression rate’’, of certain gene. The
lower the expression rate we get, the stronger inhibition
effect the siRNA is. All RT-PCR amplifications were
performed in the linear range.
Electron microscope observation and titer
1  104 cells of 20, 36, 60 and 76 h post-infection (hpi)
were centrifuged at 1000  g and the pellets were fixed in
2.5% glutaraldehyde in 0.1M phosphate buffer (pH = 7.4) for
1 day, rinsed in 0.1 M phosphate buffer containing 1%
osmium tetroxide for 1 h at 4 -C, dehydrated in a graded
ethanol series and embedded in Spurr’s resin. Ultrathin
sections were cut and stained with uranyl acetate and lead
citrate and examined in a Philips CM10 electron microscope.
Viral supernatants of 4 different time-interval groups
were diluted from 101 to 108 and used to infect FHM
cells with 6 repetitions per dilution to perform TCID50
assay. Viral titers were calculated as described by Reed–
Muench (Reed and Muench, 1938) and Spearman–Karber
method (Hamilton et al., 1977).Acknowledgments
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